The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)
NCT00045981
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
ALT-711
Sponsor
Synvista Therapeutics, Inc